Adv Ther
- BLACK PC, Eigl BJ
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk
Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast.
Adv Ther. 2024 Feb 2. doi: 10.1007/s12325-023-02763.
Am J Clin Pathol
- WEI W, Wu D, Zhang Z, Liu J, et al
Comparison of DNA methylation and cytology tests in urine to detect upper tract
urothelial carcinoma: A paired-design diagnostic study.
Am J Clin Pathol. 2024;161:115-121.
Ann Noninvasive Electrocardiol
- CHEN ZL, Jia KP, Zheng Y, Zhang N, et al
Electrocardiographic characteristics of bladder cancer patients receiving
preoperative chemotherapy combined with immunotherapy.
Ann Noninvasive Electrocardiol. 2024;29:e13107.
Anticancer Res
- ONER M, Lin E, Chiu KY, Chen MC, et al
p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher
Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer.
Anticancer Res. 2024;44:543-553.
Arch Pathol Lab Med
- OLIVER-KRASINSKI JM, Bidot S, Ingram JW, O'Toole KM, et al
Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional
Experience Focusing on Tumors With Borderline Features.
Arch Pathol Lab Med. 2024;148:223-229.
Asian J Surg
- LV HX, Wang D, Zhou FH
Definition of the prognosis value of urine extracellular vesicles ZNF540 in
bladder cancer based on GEO database.
Asian J Surg. 2024 Jan 30:S1015-9584(24)00109.
- MAO Q, Liu H, Wu J, Cui Y, et al
Prognostic significance of lncRNA AL354919.2 in bladder cancer.
Asian J Surg. 2024 Jan 25:S1015-9584(24)00099.
Biochim Biophys Acta Mol Cell Res
- ZHU C, Fang X, Liu X, Jiang C, et al
Squalene monooxygenase facilitates bladder cancer development in part by
regulating PCNA.
Biochim Biophys Acta Mol Cell Res. 2024;1871:119681.
Biomater Adv
- LIU Y, Qi P, Chen G, Lang Z, et al
Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer
immunotherapy.
Biomater Adv. 2024;157:213758.
BJU Int
- LU SM, Zhang Y, Dong XT, Wang JL, et al
Microchip for detection of cell-free DNA in urine to help identify patients with
bladder cancer.
BJU Int. 2024 Jan 30. doi: 10.1111/bju.16271.
BMC Cancer
- PAN DL, Zhang LF, Li XJ, Zhang KP, et al
Feasibility and safety of laparoscopic radical cystectomy for male octogenarians
with muscle-invasive bladder cancer.
BMC Cancer. 2024;24:159.
- VERGHOTE F, Van Praet C, Berquin C, Lumen N, et al
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a
qualitative study exploring patient priorities and counselling needs when making
a treatment choice.
BMC Cancer. 2024;24:160.
BMC Med Imaging
- ZHANG HP, Liang RX, Lin XY, Xue ES, et al
Application of contrast-enhanced ultrasound in diagnosis and grading of bladder
urothelial carcinoma.
BMC Med Imaging. 2024;24:26.
BMC Urol
- CHEN S, Sun G, Chen X, Salgado T, et al
Is switching intravesical chemotherapeutic agents beneficial in short-term
recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective
study.
BMC Urol. 2024;24:25.
Cancer Biomark
- ZHAO ZY, Cao Y, Wang HL, Liu LY, et al
A risk model based on lncRNA-miRNA-mRNA gene signature for predicting prognosis
of patients with bladder cancer.
Cancer Biomark. 2024 Jan 8. doi: 10.3233/CBM-230216.
Carcinogenesis
- PAN J, Xie X, Sheng J, Ju C, et al
Construction and identification of lncRNA/circRNA-coregulated ceRNA networks in
gemcitabine-resistant bladder carcinoma.
Carcinogenesis. 2023;44:847-858.
Cell Mol Biol (Noisy-le-grand)
- SU Y, Chen H, Yao L, Dai H, et al
The relationship between the expression of lncRNA MALAT1 and clinical features
and prognosis in bladder cancer: A meta-analysis.
Cell Mol Biol (Noisy-le-grand). 2023;69:166-171.
Cytotechnology
- YU J, Ge S
PRPF19 functions in DNA damage repair and gemcitabine sensitivity via regulating
DDB1 in bladder cancer cells.
Cytotechnology. 2024;76:85-96.
Drug Resist Updat
- LI F, Zhang H, Huang Y, Li D, et al
Single-cell transcriptome analysis reveals the association between histone
lactylation and cisplatin resistance in bladder cancer.
Drug Resist Updat. 2024;73:101059.
Emerg Med Int
- INTERNATIONAL EM
Retracted: Preoperative Nutritional Risk Assessment for Predicting Complications
after Radical Cystectomy plus Urinary Diversion for Bladder Cancer.
Emerg Med Int. 2024;2024:9849523.
Environ Toxicol
- LI P, Wang W, Zhu B, Wang Y, et al
PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in
bladder cancer.
Environ Toxicol. 2024 Jan 31. doi: 10.1002/tox.24153.
Eur Heart J Cardiovasc Imaging
- RICCHETTI G, Grimaldi A, Agricola E, Slavich M, et al
Cardiac metastasis from urothelial carcinoma: a stealthy precursor.
Eur Heart J Cardiovasc Imaging. 2024;25:e92.
Eur Urol
- BINHUMAID FS, Goel A, Gordon NS, Abbotts B, et al
Circulating Tumour Dna Detection By The Urine-Informed Analysis Of Archival Serum
Samples From Muscle-Invasive Bladder Cancer Patients.
Eur Urol. 2024 Jan 31:S0302-2838(24)00017-4. doi: 10.1016/j.eururo.2024.
Eur Urol Focus
- SORIA F, Gontero P
Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia
and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza,
Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus
Calmette-Guerin (BCG)
Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00004.
- LIN YH, Tsai HY, Juang HH
Re: Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin,
Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk
Reduction. Eur Urol Focus 2023;9:575-8.
Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00006.
Eur Urol Oncol
- MARIAPPAN P, Johnston A, Trail M, Hamid S, et al
Achieving Benchmarks for National Quality Indicators Reduces Recurrence and
Progression in Non-muscle-invasive Bladder Cancer.
Eur Urol Oncol. 2024 Jan 30:S2588-9311(24)00037.
- LOBO N, Duan Z, Sood A, Tan WS, et al
Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a
Biological Basis for Epidemiological Disparities?
Eur Urol Oncol. 2024 Jan 31:S2588-9311(24)00036.
Eur Urol Open Sci
- NARDELLI C, Aveta A, Pandolfo SD, Tripodi L, et al
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine
Sample.
Eur Urol Open Sci. 2023;59:18-26.
Front Immunol
- YANG H, Ma L, Deng W, Fu B, et al
Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor.
Front Immunol. 2024;14:1301945.
- XU Y, Sun X, Liu G, Li H, et al
Integration of multi-omics and clinical treatment data reveals bladder cancer
therapeutic vulnerability gene combinations and prognostic risks.
Front Immunol. 2024;14:1301157.
- SCHNEIDER AK, Domingos-Pereira S, Cesson V, Polak L, et al
Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.
Front Immunol. 2024;14:1335326.
Front Oncol
- MONSHAUGEN I, Luna L, Rhodes J, Kristiansen FIS, et al
Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance
against cellular stress in bladder cancer.
Front Oncol. 2024;13:1334112.
Front Pharmacol
- ZHU S, Zhao H
Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis,
and outcomes.
Front Pharmacol. 2024;14:1326627.
Heliyon
- WEI Z, Liu H, Xv Y, Liao F, et al
Development and validation of a CT-based deep learning radiomics nomogram to
predict muscle invasion in bladder cancer.
Heliyon. 2024;10:e24878.
Int J Mol Sci
- JO A, Joh HM, Bae JH, Kim SJ, et al
Plasma-Activated Media Produced by a Microwave-Excited Atmospheric Pressure
Plasma Jet Is Effective against Cisplatin-Resistant Human Bladder Cancer Cells In
Vitro.
Int J Mol Sci. 2024;25:1249.
- LUMKUL L, Jantaree P, Jaisamak K, Wongkummool W, et al
Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs
to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic
Review and Meta-Analysis.
Int J Mol Sci. 2024;25:1258.
Int J Pharm
- REN Y, Liu T, Li S, Ma X, et al
An iodine?labelled Antibody-drug conjugate PET probe for noninvasive monitoring
of Nectin-4 expression in urothelial carcinoma.
Int J Pharm. 2024;651:123756.
Int J Rheum Dis
- BANDEIRA M, Dourado E, Lopes F, Tenazinha C, et al
Reactive arthritis as a rare complication of intravesical bacillus
Calmette-Guerin treatment: Report of two cases.
Int J Rheum Dis. 2024;27:e14862.
iScience
- WANG J, Tan J, Zhang Y, Zhou L, et al
circCD2AP promotes epithelial mesenchymal transition and stemness in bladder
cancer by regulating FOXQ1/USP21 axis.
iScience. 2023;27:108447.
J Cancer Surviv
- BAHLBURG H, Reicherz A, Reike M, Bach P, et al
A prospective evaluation of quality of life, psychosocial distress, and
functional outcomes two years after radical cystectomy and urinary diversion in
842 German bladder cancer patients.
J Cancer Surviv. 2024 Jan 30. doi: 10.1007/s11764-024-01535.
J Control Release
- SUN Y, Lu Z, Taylor JA, Au JLS, et al
Quantitative image analysis of intracellular protein translocation in
3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
J Control Release. 2024;365:89-100.
J Endourol
- BAUST JM, Corcoran A, Robilotto A, Katz AE, et al
Evaluation of a New Cystoscopic Cryocatheter and Method for the In Situ
Destruction of Bladder Cancer: Preliminary In vivo Study.
J Endourol. 2024 Jan 27. doi: 10.1089/end.2023.0635.
J Extracell Vesicles
- DONG L, Feng M, Kuczler MD, Horie K, et al
Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of
bladder cancer.
J Extracell Vesicles. 2024;13:e12402.
J Gene Med
- SU H, Liu Z, Zhang C, Deng Z, et al
Exploration of the prognostic effect of costimulatory genes in bladder cancer.
J Gene Med. 2024;26:e3655.
- JIANG S, Yang X, Lin Y, Liu Y, et al
Unveiling Anoikis-related genes: A breakthrough in the prognosis of bladder
cancer.
J Gene Med. 2024;26:e3651.
- WANG CS, Lee YC, Jhan JH, Li WM, et al
MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis
via VEGFA in upper tract urothelial carcinoma.
J Gene Med. 2024;26:e3616.
J Mol Diagn
- ABE M, Hiraki H, Tsuyukubo T, Ono S, et al
The clinical validity of urinary pellet DNA monitoring for the diagnosis of
recurrent bladder cancer.
J Mol Diagn. 2024 Jan 30:S1525-1578(24)00012.
J Urol
- KAY H, Matulewicz RS, Bjurlin MA
Clearing the Smoke: Underreporting of Smoking Status in Food and Drug
Administration-Approved Bladder Cancer Therapeutic Trials.
J Urol. 2024 Feb 1:101097JU0000000000003853. doi: 10.1097/JU.0000000000003853.
JCO Glob Oncol
- MANNEH KOPP R, Galanternik F, Schutz FA, Kater F, et al
Latin American Consensus for the Evaluation and Treatment of Patients With
Metastatic/Locally Advanced Urothelial Carcinoma.
JCO Glob Oncol. 2024;10:e2300244.
JNMA J Nepal Med Assoc
- MISHRA P, Jiongming L, Jianhe L, Kewei F, et al
Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder
Cancer in the Department of Urology in a Tertiary Care Centre.
JNMA J Nepal Med Assoc. 2023;61:782-786.
Nan Fang Yi Ke Da Xue Xue Bao
- YAN Q, Zeng P, Huang S, Tan C, et al
[RBMX overexpression inhibits proliferation, migration, invasion and glycolysis
of human bladder cancer cells by downregulating PKM2].
Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:9-16.
Nat Rev Clin Oncol
- KLEMM J, Laukhtina E, Shariat SF
Combination neoadjuvant therapies are paving the way for bladder preservation to
become the standard for selected patients.
Nat Rev Clin Oncol. 2024;21:87-88.
Nat Rev Urol
- GROBET-JEANDIN E, Lenfant L, Pinar U, Parra J, et al
Management of patients with muscle-invasive bladder cancer with clinical evidence
of pelvic lymph node metastases.
Nat Rev Urol. 2024 Jan 31. doi: 10.1038/s41585-023-00842.
Nucleosides Nucleotides Nucleic Acids
- BOSTANCI E, Kirkik D, Kalkanli Tas S, Uyeturk U, et al
Genetic insights into bladder cancer: the impact of SIRT1 gene polymorphism.
Nucleosides Nucleotides Nucleic Acids. 2024.
Phys Med Biol
- YU J, Cai L, Chen C, Zou Y, et al
A novel predict method for muscular invasion of bladder cancer based on 3D mp-MRI
feature fusion.
Phys Med Biol. 2024 Feb 2. doi: 10.1088/1361-6560.
PLoS One
- KVIKSTAD V, Lillesand M, Gudlaugsson E, Mangrud OM, et al
Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting
prognosis of non-muscle invasive papillary urothelial carcinomas.
PLoS One. 2024;19:e0297141.
Sci Rep
- NIE Z, Guo N, Peng Y, Gao Y, et al
Author Correction: Duality of the SVIL expression in bladder cancer and its
correlation with immune infiltration.
Sci Rep. 2024;14:2369.
- IIDA K, Naiki T, Etani T, Nagai T, et al
Proton pump inhibitors and potassium competitive acid blockers decrease
pembrolizumab efficacy in patients with metastatic urothelial carcinoma.
Sci Rep. 2024;14:2520.
- DEMIR R, Koc S, Ozturk DG, Bilir S, et al
Artificial intelligence assisted patient blood and urine droplet pattern analysis
for non-invasive and accurate diagnosis of bladder cancer.
Sci Rep. 2024;14:2488.
- WANG H, Liu J, Lou Y, Liu Y, et al
Identification and preliminary analysis of hub genes associated with bladder
cancer progression by comprehensive bioinformatics analysis.
Sci Rep. 2024;14:2782.
Toxicol Res (Camb)
- LIU Z, Du D, Zhang S
Integrated bioinformatics analysis identifies a Ferroptosis-related gene
signature as prognosis model and potential therapeutic target of bladder cancer.
Toxicol Res (Camb). 2024;13:tfae010.
Urol Oncol
- PORRECA A, Di Nicola M, Lucarelli G, Dorin VM, et al
Time to progression is the main predictor of survival in patients with high-risk
nonmuscle invasive bladder cancer: Results from a machine learning-based analysis
of a large multi-institutional database.
Urol Oncol. 2024 Jan 31:S1078-1439(24)00003.
- LOTAN Y, Agarwal P, Black P, Dickstein R, et al
Standardization of the evaluation and surveillance of patients with BCG
unresponsive high grade non-muscle invasive bladder cancer clinical trials.
Urol Oncol. 2024 Feb 1:S1078-1439(24)00020-6. doi: 10.1016/j.urolonc.2024.
Urol Pract
- SEGEL JE, Wong WG, Kaag M, Joshi M, et al
Relationship Between Availability of Urologists and Primary Care Providers and
Stage of Diagnosis for Invasive Urinary Bladder Cancer.
Urol Pract. 2024 Jan 15:101097UPJ0000000000000503.
Urology
- MORRIS KE, Pappas TN
Malignancy in the public life: the story of Hubert Humphrey's bladder cancer.
Urology. 2024 Jan 31:S0090-4295(24)00017-7. doi: 10.1016/j.urology.2023.
Zhonghua Bing Li Xue Za Zhi
- HUANG WQ, Zhang L, Fu S, Shi GZ, et al
[Mesonephric-like adenocarcinoma of the female urinary bladder associated with
endometriosis: report of a case].
Zhonghua Bing Li Xue Za Zhi. 2024;53:201-203.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016